Immunotherapy is redefining survivorship to include an increasing population of patients who live with cancer and navigate toxicities that differ from those that accompany traditional treatments. In this episode, CANCER BUZZ speaks with Brittney Baer, BSN, RN, patient care coordinator for the Immune Effector Cell program at Vanderbilt University Medical Center’s Vanderbilt-Ingram Cancer Center, about key strategies and solutions to prioritize patient quality of life by addressing barriers to holistic survivorship care. 

“I think simply talking to your patients and seeing what they would like to see [in terms of survivorship care] out of your cancer center—you don't have to start a huge holistic program right away...whether it be a nutritional program, a one-day-a-week meditation class, or a yoga class...start small and then start growing from there.”—Brittney Baer, BSN, RN

Brittney Baer, BSN, RN

Patient Care Coordinator, Immune Effector Cell Program 

Vanderbilt University Medical Center - Vanderbilt-Ingram Cancer Center 

 Nashville, TN 

This episode was made possible by support from Bristol Myers Squibb and developed in connection with ACCC’s Immuno-Oncology Institute, which is made possible by support from Bristol Myers Squibb, Merck & Co., and AstraZeneca.

Resources:

About the Institute - ACCC 

IO Institute Survivorship Resources 

State of Survivorship Survey - NCCS